According to the business intelligence report titled ‘GLOBAL Molecular Point Of Care Diagnostics Market 2019-2028’, available with Market Study Report, global molecular point of care diagnostics market is projected to expand with a robust compound annual growth rate of 14.05% over the forecast period of 2019-2028.
 

As per the findings of the report, surging demand for diagnostic technology amidst the ongoing COVID-19 pandemic coupled with rising adoption of non-invasive surgical procedures are catalyzing global molecular point of care diagnostics market growth.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3552864/
 

Strategic alliances such as acquisitions, partnerships, and mergers among leading companies, technological advancements, and introduction of innovative solutions as well as products are adding considerable traction to the industry expansion.
 

Additionally, growing prevalence of chronic diseases, rising disposable incomes, and increasing investments towards research & development activities are positively swaying global molecular point of care diagnostics market dynamics.
 

Despite the optimistic outlook of the market, lack of high complexity test centers along with excessive initial capital requirements may potentially obstruct business development in the coming impending years.
 

Geographically speaking, the overall industry vertical is fragmented into North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
 

Among these, Asia-Pacific molecular point of care diagnostics market is set to amass significant returns during 2019-2028. Escalating demand for the diagnostics procedure in Japan along with favorable government initiatives aimed at promoting the adoption of precision medicine solutions are bolstering the regional market expansion.
 

Speaking of competitive scenario, DiaSorin S.p.A, QuantuMDx Group Ltd., Spartan Biosciences Inc., Biocartis Group, Mesa Biotech Inc., bioMérieux S.A., Qiagen N.V., Danaher Corporation, Abacus Diagnostica Oy, Hologic Inc., Bio-Rad Laboratories Inc., Luminex Corporation, F. Hoffmann-La Roche AG Abbott Laboratories, and Quidel Corporation are the top organizations operating in worldwide molecular point of care diagnostics market sphere.